The global diabetes market is experiencing rapid growth driven by the increasing prevalence of this chronic disease. At the forefront of this evolution are leading companies of GLP-1 receptor agonists, a class of drugs https://cyrusjgyb555963.losblogos.com/36377375/leading-glp-1-manufacturers-innovation-in-diabetes-treatment